Saturn V Capital Management

Latest statistics and disclosures from Saturn V Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Saturn V Capital Management

Saturn V Capital Management holds 26 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Argenx Se Sponsored Adr (ARGX) 10.4 $28M -2% 64k 430.04
 View chart
Disc Medicine (IRON) 8.6 $23M +97% 503k 45.07
 View chart
Crinetics Pharmaceuticals In (CRNX) 8.1 $22M -27% 480k 44.79
 View chart
Vaxcyte (PCVX) 6.2 $16M +16% 216k 75.51
 View chart
Ascendis Pharma A/s Sponsored Adr (ASND) 5.8 $15M +9% 113k 136.38
 View chart
Cytokinetics Com New (CYTK) 5.6 $15M +3% 272k 54.18
 View chart
BioMarin Pharmaceutical (BMRN) 5.6 $15M +49% 179k 82.33
 View chart
Cogent Biosciences (COGT) 5.3 $14M +4% 1.7M 8.43
 View chart
Cargo Therapeutics (CRGX) 5.3 $14M NEW 857k 16.42
 View chart
Kalvista Pharmaceuticals (KALV) 5.0 $13M -21% 1.1M 11.78
 View chart
Celcuity (CELC) 4.7 $13M NEW 761k 16.38
 View chart
Merus N V (MRUS) 3.7 $9.7M -56% 165k 59.17
 View chart
Syndax Pharmaceuticals (SNDX) 3.3 $8.6M +5% 420k 20.53
 View chart
Abivax Sa Sponsored Ads (ABVX) 3.1 $8.3M 628k 13.22
 View chart
Ironwood Pharmaceuticals Com Cl A (IRWD) 2.7 $7.3M +17% 1.1M 6.52
 View chart
Amicus Therapeutics (FOLD) 2.7 $7.1M -20% 714k 9.92
 View chart
Anaptysbio Inc Common (ANAB) 2.4 $6.3M -57% 250k 25.06
 View chart
Phathom Pharmaceuticals (PHAT) 2.3 $6.1M +18% 593k 10.30
 View chart
Iteos Therapeutics (ITOS) 2.1 $5.5M -5% 367k 14.84
 View chart
Inozyme Pharma (INZY) 1.9 $5.1M NEW 1.1M 4.46
 View chart
Neumora Therapeutics (NMRA) 1.4 $3.8M NEW 390k 9.83
 View chart
Enliven Therapeutics (ELVN) 1.3 $3.6M NEW 152k 23.37
 View chart
Longboard Pharmaceuticals In (LBPH) 0.7 $1.9M NEW 71k 27.03
 View chart
Rapport Therapeutics (RAPP) 0.6 $1.6M NEW 70k 23.26
 View chart
Morphic Hldg (MORF) 0.6 $1.6M -44% 48k 34.07
 View chart
Contineum Therapeutics Cl A (CTNM) 0.5 $1.3M NEW 73k 17.61
 View chart

Past Filings by Saturn V Capital Management

SEC 13F filings are viewable for Saturn V Capital Management going back to 2022